newsfilter
← Latest News
PR Newswire·

BioLineRx Announces $10 Million Registered Direct Offering

BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-changing...